Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Perioperative management of antiplatelet therapy in patients with drug-eluting stents.

Dimitrova G, Tulman DB, Bergese SD.

HSR Proc Intensive Care Cardiovasc Anesth. 2012;4(3):153-67.

2.

Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(12):1-97. Epub 2006 Apr 1.

3.

Coronary stent management in elective genitourinary surgery.

Gupta AD, Streiff M, Resar J, Schoenberg M.

BJU Int. 2012 Aug;110(4):480-4. doi: 10.1111/j.1464-410X.2011.10821.x. Epub 2011 Dec 22. Review.

4.
5.

Perioperative antiplatelet management in patients with coronary artery stenting.

Tandar A, Velagapudi KN, Wilson BD, Boden WE.

Hosp Pract (1995). 2012 Apr;40(2):118-30. doi: 10.3810/hp.2012.04.977. Review.

PMID:
22615086
6.

Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

Newsome LT, Kutcher MA, Royster RL.

Anesth Analg. 2008 Aug;107(2):552-69. doi: 10.1213/ane.0b013e3181732049. Review.

PMID:
18633035
7.

[Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].

Rossini R, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Musumeci G, Visconti LO, Piccaluga E, Savonitto S, Trabattoni D, Buffoli F, Angiolillo DJ, Bovenzi F, Cremonesi A, Scherillo M, Guagliumi G; Società Italiana di Cardiologia Invasiva (GISE); Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO).

G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):528-51. doi: 10.1714/1114.12251. Italian.

PMID:
22781382
8.

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB 3rd, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ Jr, Nicolela EL Jr, Perin MA, Devito FS, Labrunie A, Salvadori D Jr, Gusmão M, Staico R, Costa JR Jr, de Castro JP, Abizaid AS, Bhatt DL; OPTIMIZE Trial Investigators.

JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.

PMID:
24177257
9.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators.

JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. Erratum in: JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913.

10.

Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.

Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M.

Tex Heart Inst J. 2010;37(3):343-6. Review.

11.

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G; PRODIGY Investigators.

JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.

12.

Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.

Khair T, Garcia B, Banerjee S, Brilakis ES.

Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):99-104. doi: 10.1016/j.carrev.2009.09.007. Epub 2010 Oct 20.

PMID:
21421188
13.

Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.

Singh T, Cuomo L, Cohen M, Ahmad HA, Aronow WS.

Curr Clin Pharmacol. 2013 Feb 1;8(1):59-66. Review.

PMID:
22946865
14.

Organ transplantation and drug eluting stents: Perioperative challenges.

Dalal A.

World J Transplant. 2016 Dec 24;6(4):620-631. doi: 10.5500/wjt.v6.i4.620. Review.

15.

Coronary artery stents: II. Perioperative considerations and management.

Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL.

Anesth Analg. 2008 Aug;107(2):570-90. doi: 10.1213/ane.0b013e3181731e95. Review.

PMID:
18633036
16.

Brief review: coronary drug-eluting stents and anesthesia.

Dalal AR, D'Souza S, Shulman MS.

Can J Anaesth. 2006 Dec;53(12):1230-43. Review.

PMID:
17142658
17.

Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS.

JAMA. 2008 Jun 25;299(24):2868-76. doi: 10.1001/jama.299.24.2868.

19.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105. JAMA. 2015 Jun 2;313(21):2185.

20.

Late and very late drug-eluting stent thrombosis in the immediate postoperative period after antiplatelet withdrawal: a retrospective study.

Omar HR, Sprenker C, Karlnoski R, Camporesi EM, Mangar D.

Ther Adv Cardiovasc Dis. 2014 Oct;8(5):185-92. doi: 10.1177/1753944714542592. Epub 2014 Jul 10.

PMID:
25015068

Supplemental Content

Support Center